分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

X-ray preactivated reversible persistent luminescence enables photodynamic immunotherapy of deep tumors

Topatana Win, Sun Yuchao, Xie Tianao, Zhu Yiyuan, Yang Taorui, Shen Ruijing, Ran Peng, Li Chengao, Chen Jiadong, Shen Xuqiu, Lu Ziyi, Han Yina, Shan Yukai, Li Shijie, Chen Tianen, Cai Xiujun, Deng Re

Journal:Nature Communications

IF:18.1

DOI:10.1038/s41467-026-71028-4

PMID:41865031

Published:2026-03-21

research field:肿瘤学光动力治疗生物医学工程免疫治疗纳米医学

Abstract

Persistent luminescence is a promising approach for photodynamic therapy (PDT) in deep-seated tumors, as it provides sustained light within tissues, eliminating the need for continuous external illumination. However, the uncontrollability of light within the body complicates precise spatiotemporal regulation. In this study, we report X-ray preactivated elimusertib-loaded tumor-targeted photodynamic nanoparticles (ETPNs), featuring reversible “on-off” afterglow properties. The excellent afterglow properties of X-ray-activated porous NaYF 4 :Er@NaGdF 4 persistent luminescence nanoparticles enable the continuous activation of chlorin e6 (Ce6) to generate reactive oxygen species (ROS), leading to DNA damage. The integration of elimusertib potentiates ROS-induced DNA damage and activates the cGAS-STING pathway, thereby enhancing immuno-photodynamic therapeutic efficacy. All in vivo experiments were conducted using female mice. Our findings highlight the potential of ETPNs to advance the therapeutic landscape for deep-seated tumors, offering a robust and controllable platform for combined immuno-photodynamic therapy.

本文使用的Yeasen产品

购物车
客服
转染试用